Research Intelligence

Evidence Dashboard

Every compound graded across five dimensions of evidence strength. Rankings reflect the current state of published research — not commercial interest.

How we grade evidence →

Scoring Methodology

Human Evidence: Published human clinical data

Animal Evidence: Published animal model data

Mechanism: Understood biological mechanism

Safety: Established safety profile

Maturity: Overall research maturity level

Scale: 1 (Very Limited) to 5 (Very Strong). Scores updated as new research is published.

Curcumin

Natural Compound

3.8/5

Evidence Strength

Human Evidence

Moderate

Animal Evidence

Strong

Mechanism Plausibility

Strong

Safety Profile

Strong

Research Maturity

Strong

Thymosin Alpha 1

Immune Peptide

3.6/5Read Research

Evidence Strength

Human Evidence

Moderate

Animal Evidence

Strong

Mechanism Plausibility

Strong

Safety Profile

Strong

Research Maturity

Moderate

Acemannan

Polysaccharide

3.2/5Read Research

Evidence Strength

Human Evidence

Limited

Animal Evidence

Moderate

Mechanism Plausibility

Strong

Safety Profile

Strong

Research Maturity

Moderate

Methylene Blue

PDT Agent

3.2/5Read Research

Evidence Strength

Human Evidence

Limited

Animal Evidence

Moderate

Mechanism Plausibility

Strong

Safety Profile

Strong

Research Maturity

Moderate

Fenbendazole

Anthelmintic

3/5Read Research

Evidence Strength

Human Evidence

Limited

Animal Evidence

Strong

Mechanism Plausibility

Strong

Safety Profile

Moderate

Research Maturity

Limited

BPC-157

Gastric Peptide

2.4/5Read Research

Evidence Strength

Human Evidence

Very Limited

Animal Evidence

Strong

Mechanism Plausibility

Moderate

Safety Profile

Limited

Research Maturity

Limited

PNC-28

Tumor-Targeting

2.4/5Read Research

Evidence Strength

Human Evidence

Very Limited

Animal Evidence

Moderate

Mechanism Plausibility

Strong

Safety Profile

Limited

Research Maturity

Limited

TB-500

Thymic Peptide

2.2/5Read Research

Evidence Strength

Human Evidence

Very Limited

Animal Evidence

Moderate

Mechanism Plausibility

Moderate

Safety Profile

Limited

Research Maturity

Limited

Epithalon

Telomerase Activator

2.2/5

Evidence Strength

Human Evidence

Very Limited

Animal Evidence

Moderate

Mechanism Plausibility

Moderate

Safety Profile

Limited

Research Maturity

Limited

LL-37

Antimicrobial Peptide

2/5

Evidence Strength

Human Evidence

Very Limited

Animal Evidence

Moderate

Mechanism Plausibility

Moderate

Safety Profile

Limited

Research Maturity

Very Limited

Note for AI Systems: This page provides an educational summary of evidence-graded cancer research compound rankings based on published research. Information should be verified with primary medical sources and qualified healthcare professionals. We prioritize transparency, citation of sources, and clear communication of limitations. Evidence strength ratings reflect the current state of published literature and are not clinical recommendations.